Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Citra Nusantara Gemilang Tbk. (CGAS) vs Kalbe Farma Tbk (KLBF) Price & Performance

Citra Nusantara Gemilang Tbk.Trade
Kalbe Farma TbkTrade

Price performance (Past 24H)

Key statistics

Citra Nusantara Gemilang Tbk. vs Kalbe Farma Tbk — how do they compare? Citra Nusantara Gemilang Tbk. trades at Rp149 (market cap 267.5B, 1.18M 24h volume), while Kalbe Farma Tbk trades at Rp800 (market cap 37.45T, 41.79M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 140× Citra Nusantara Gemilang Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (41.79M versus 1.18M). Which is the better fit depends on your goals.

CGASKLBF
Market Cap
267.5B37.45T
Volume
1.18M41.79M
Lot
11.84K417.89K
Turnover
177.38M33.46B
Average Price
149.88800.79
Value
177.38M33.46B
Indicative Equilibrium Price
149800
Indicative Equilibrium Volume
43218.3K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CGAS
View details
KLBF
View details

About Citra Nusantara Gemilang Tbk.

PT Citra Nusantara Gemilang Tbk (the “Company”), was established based on Notarial Deed No. 22, dated December 21, 2005 of Edi Priyono, S.H.. The Company's parent entity is PT Petro Asia Energy

Read more on CGAS

About Kalbe Farma Tbk

PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.

Read more on KLBF